Near-infrared light fluorescence in mice optimizes tumor removal, reduces cancer recurrence

NAVIGATOR data show half of patients with severe, uncontrolled asthma improved with tezepelumab therapy
17 May 2022
Less than 1% of abortions take place in the third trimester: Here’s why people get them
17 May 2022

Near-infrared light fluorescence in mice optimizes tumor removal, reduces cancer recurrence

Nearly 13% of women born in the U.S. today will develop breast cancer at some point during their lives. Treatment for early-stage disease often includes breast-conserving surgery, where the tumor and some surrounding healthy tissue (the tumor margin) are removed. However, around 20% of these surgeries require a second operation, generally because cancer cells are found within the tumor margins.

Comments are closed.